White House Reaches Agreement With Regeneron to Lower Drug Costs

President Donald Trump on Thursday announced a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House’s signature drug pricing initiative. The deal involves Regeneron lowering the prices of all its current and future drugs on Medicaid, according to Trump. It also involves selling a cholesterol drug […]

Go to News Site